Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment Options funds researchers’ studies to assess real-world treatment outcomes.
Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI) supports researchers studying diagnostic-guided treatment of resistant infections to assess timeliness and effectiveness.
Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment Options supports investigators studying tissue exposure to understand links to treatment outcomes.
Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophilia supports healthcare teams' local quality improvement projects to improve diagnosis, treatment, and adult care.
The ATS Unrestricted & Emerging Voices in Health Research Grants fund innovative early-career research in pulmonary, critical care, and sleep medicine, with a focus on diversity and inclusion.